Close Menu
Home › JP Morgan Healthcare, Day 4: OraSure, Meridian Bioscience, Biocartis, Veracyte

JP Morgan Healthcare, Day 4: OraSure, Meridian Bioscience, Biocartis, Veracyte

Jan 11, 2019
|
Leo O'Connor
|
Monica Heger

SAN FRANCISCO (GenomeWeb) - The 37th annual JP Morgan Healthcare Conference came to a close on Thursday with a few diagnostics companies presenting to attendees who stuck around to the end. Below are brief reports on the presentations and breakout sessions covered by our team at the conference and in our offices in New York.

For all of our previous coverage of the conference, please this page on our website.

OraSure Technologies

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03
Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
10
Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Molecular Diagnostics

  1. Natera Finds High Performance for Noninvasive Prenatal Test in All Age Groups

    Premium

  2. Exact Sciences Stock Falls on Publication of New CRC Screening Cost-Effectiveness Study

  3. Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers

  4. Myriad Genetics, University of Leeds Collaborate on Prolaris Clinical Utility Study

  5. BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.